-

MTF Biologics Appoints Jeff Orlowski to Board of Directors

EDISON, N.J.--(BUSINESS WIRE)--MTF Biologics, a global nonprofit organization that saves and heals lives by honoring donated gifts, serving patients, and advancing the science of tissue transplantation, today announced that LifeShare of Oklahoma President and Chief Executive Officer Jeff Orlowski has joined its Board of Directors.

“We are honored to welcome Jeff to our Board,” said Joe Yaccarino, president and CEO of MTF Biologics. “He knows our organization well and has a great depth of experience with and understanding of the intricacies of organ and tissue donation as well as a commitment to excellence in service to donors, families and recipients. Jeff brings an added dimension and perspective to our Board that will help us advance our mission of saving and healing lives.”

Orlowski has 35 years of experience in organ and tissue donation. He has led LifeShare of Oklahoma for more than 11 years, and currently serves as president and CEO of LifeShare Donor Network and its subsidiary organizations and as president of the LifeShare Foundation. In addition to his roles at LifeShare, Orlowski serves as United Network for Organ Sharing (UNOS) Region 4 Councilor, as a Councilor for the International Society of Donation and Procurement, and as a member of the UNOS Board, the Organ Procurement and Transplant Network (OPTN) Board, the OPTN Executive Committee, the UNOS Corporate Affairs Committee, the UNOS and OPTN Finance Committees, the Donation Board of Trustees for MTF Biologics, and the Association of Organ Procurement Organizations (AOPO) Leadership Development Committee. He also is Chair of the Oklahoma Governor’s Advancement of Wellness Advisory Council.

A Past President of AOPO and Donate Life America, Orlowski has served on numerous other Boards and been honored with awards including 55over55 Inspiring Oklahomans, AATB Jeanne C. Mowe Distinguished Service Award, AOPO/Sallop “Excellence in Leadership” Award, AOPO President’s Award, and the 2020 Top Midsize Business Leader by The Daily Oklahoman Best Places to Work. He has authored or co-authored more than 50 peer-reviewed journal articles and has presented more than 100 scientific abstracts and invited lectures around the world.

“I am honored to join the MTF Biologics Board and to represent the nation’s recovery programs in this capacity,” said Orlowski. “I have had the honor of working with MTF Biologics as a recovery partner since 1995 and am excited to bring that perspective to the organization’s Board. As the world’s leader in its field, MTF Biologics has a well-deserved reputation for excellence, and I look forward to contributing to that legacy.”

About MTF Biologics

MTF Biologics is a global nonprofit organization that saves and heals lives by honoring donated gifts, serving patients and advancing science. They provide unmatched service, resources, and expertise to donors and their loved ones who give the gift of donation, people who depend on tissue and organ transplants, healthcare providers, and clinicians and scientists.

The International Institute for the Advancement of Medicine (IIAM), a Division of MTF Biologics, honors donors of non-transplantable organs by providing their gifts to the medical research community to combat and cure diseases. Statline, also a Division of MTF Biologics, provides specialized communications and technology expertise to organ, tissue, and eye procurement organizations, as well as the hospitals and patients that they serve. MTF Biologics’ sister organization, Deutsches Institute for Zell-und Gewebeersatz – DIZG (The German Institute for Cell and Tissue Transplantation) expands its reach to patients across the globe. For more information, visit www.mtfbiologics.org.

About LifeShare of Oklahoma

LifeShare Network, Inc. serves as the parent company for LifeShare Transplant Donor Services of Oklahoma, Inc., the only federally authorized Organ Procurement Organization (OPO) for the state of Oklahoma, LifeShare Tissue Services, Inc., and LifeShare Innovations, LLC. The LifeShare Network and its subsidiaries exist with community support from the LifeShare Foundation, Inc. The LifeShare Network, Inc. serves as the administrative resource to its subsidiaries allowing them to focus on their primary functions of procuring more organs and tissue resulting in more lives saved.

Contacts

MTF Biologics


Release Summary
LifeShare of Oklahoma President and Chief Executive Officer Jeff Orlowski has joined the Board of Directors of global nonprofit MTF Biologics.
Release Versions

Contacts

More News From MTF Biologics

MTF Biologics’ AmnioBand® Membrane and AlloPatch® Pliable Confirmed as Covered Under Updated CMS Local Coverage Determinations

EDISON, N.J.--(BUSINESS WIRE)--MTF Biologics, a global nonprofit organization that saves and heals lives by honoring donated gifts and advancing the science of tissue transplantation, today announced that two of its aseptically processed allografts without terminal irradiation, AmnioBand® Membrane, an allograft placental matrix, and AlloPatch® Pliable an allograft dermal matrix, will remain among the 18 tissues covered under the newly updated Medicare Local Coverage Determinations (LCDs) for sk...

MTF Biologics and Kolosis BIO Launch Two New Allografts to Advance Cardiac Surgery

EDISON, N.J. & SALT LAKE CITY--(BUSINESS WIRE)--MTF Biologics, a global nonprofit organization that saves and heals lives by advancing tissue and organ donation, transplantation, and research, and Kolosis BIO (Kolosis), a premier provider of biologic solutions, today announced they have partnered to bring two innovative allograft tissues to cardiac surgeons: ATLAS™ Sternal Repair Matrix for sternal fusion and IKON™ Allograft Surgical Matrix for soft tissue repair in high-risk patients. These hi...

MTF Biologics Completes First Implantation of FlexHD® Pliable in Milestone Breast Reconstruction Clinical Trial

EDISON, N.J.--(BUSINESS WIRE)--MTF Biologics, a global nonprofit organization that saves and heals lives by advancing tissue and organ donation, transplantation, and research, today announced the successful implantation of FlexHD® Pliable in the first patient enrolled in its Investigational Device Exemption (IDE) clinical study for pre-pectoral breast reconstruction. This milestone pivotal study (SHAPE) aims to evaluate the safety and effectiveness of FlexHD® Pliable in implant-based breast rec...
Back to Newsroom